Price T Rowe Associates Inc Bicycle Therapeutics PLC Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,468,393 shares of BCYC stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,468,393

Previous 1,536,584 4.44%

Holding current value

$10.6 Million

Previous $13 Million 21.77%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.38 - $9.3 $435,058 - $634,176	-68,191 Reduced 4.44%	1,468,393 $10.2 Million
Q1 2025 May 14, 2025	SELL	$8.49 - $15.16 $412,130 - $735,911	-48,543 Reduced 3.06%	1,536,584 $13 Million
Q4 2024 Feb 14, 2025	SELL	$13.81 - $27.5 $1.89 Million - $3.77 Million	-136,913 Reduced 7.95%	1,585,127 $22.2 Million
Q3 2024 Nov 14, 2024	BUY	$19.58 - $27.24 $18.1 Million - $25.2 Million	923,539 Added 115.66%	1,722,040 $39 Million
Q2 2024 Aug 14, 2024	BUY	$20.02 - $24.69 $7.95 Million - $9.8 Million	396,855 Added 98.81%	798,501 $16.2 Million
Q1 2024 May 15, 2024	BUY	$16.75 - $26.1 $2.09 Million - $3.26 Million	124,809 Added 45.08%	401,646 $10 Million
Q4 2023 Feb 14, 2024	SELL	$13.29 - $22.2 $4.2 Million - $7.02 Million	-316,216 Reduced 53.32%	276,837 $5.01 Million
Q3 2023 Nov 14, 2023	BUY	$19.9 - $26.25 $5.89 Million - $7.76 Million	295,768 Added 99.49%	593,053 $11.9 Million
Q2 2023 Aug 14, 2023	SELL	$18.95 - $28.67 $393,989 - $596,077	-20,791 Reduced 6.54%	297,285 $7.59 Million
Q1 2023 May 15, 2023	SELL	$20.02 - $31.37 $413,553 - $648,010	-20,657 Reduced 6.1%	318,076 $6.77 Million
Q4 2022 Feb 14, 2023	SELL	$20.37 - $32.9 $1.6 Million - $2.59 Million	-78,607 Reduced 18.84%	338,733 $10 Million
Q3 2022 Nov 14, 2022	SELL	$17.49 - $28.44 $68,578 - $111,513	-3,921 Reduced 0.93%	417,340 $9.71 Million
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $3.43 Million - $12.4 Million	-264,615 Reduced 38.58%	421,261 $7.07 Million
Q1 2022 May 16, 2022	SELL	$40.12 - $59.5 $4.42 Million - $6.55 Million	-110,138 Reduced 13.84%	685,876 $30.1 Million
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $33.2 Million - $48.7 Million	796,014 New	796,014 $48.5 Million

Others Institutions Holding BCYC

# of Institutions

113

Shares Held

41.9M

Call Options Held

111K

Put Options Held

16.6K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $214M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Bicycle Therapeutics PLC Transaction History